A consistent and reproducible model for drug development, toxicity testing and disease modelling applications Cambridge, UK – Axol Bioscience, the human cell culture specialists, provide highly validated primary cells and iPSC-derived cells together with optimised media and growth supplements, launch their Human iPSC-derived Atrial Cardiomyocytes for the discovery and development of novel treatments and advancing our understanding of […]
Cellectricon, a collaborative services provider dedicated to advance drug discovery and research in the areas of chronic pain and CNS disease, has appointed Professor Henrik Zetterberg to its scientific advisory board. Professor Zetterberg brings extensive expertise in Alzheimer’s disease and other neurodegenerative brain disorders. Professor Zetterberg, MD, PhD, is Professor of Neurochemistry at the University […]
Cellenion and Miltenyi Biotec Sign Co-Marketing Agreement to Provide a Time and Cost-Efficient Solution for the Development of Monoclonal Cell Lines Combined use of MACSQuant® Tyto® Cell Sorter and cellenONE® X1 single-cell deposition unit allows for time- and cost-efficient production of high-expressing and fast-expanding monoclonal cell lines. Berlin and Bergisch Gladbach, Germany: SCIENION AG and Miltenyi Biotec GmbH […]
Under this agreement, MaxCyte’s second signed with a U.S. NIH institute in the past year, the Company and the National Heart, Lung, and Blood Institute will explore development of new therapies for sickle cell disease using MaxCyte’s gene-correction platform Gaithersburg, Maryland – MaxCyte, Inc. today announces it has entered into a Cooperative Research and Development Agreement (“CRADA”) […]
Ensures validity and reliability of data from cell culture-based research MANASSAS, Va. — ATCC, the premier global biological materials resource and standards organization and the leading supplier of authenticated cells and advanced cell models, today announced the availability of its new PCR-based service to detect mycoplasma contamination in cell cultures. This growing service portfolio is […]
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has established a new subsidiary in Egypt and will begin conducting direct sales and services with the aim of expanding its business in the Middle East. In recent years, Egypt has been setting up healthcare infrastructure in line with the country’s economic expansion and population […]
SOMERSET, N.J. – Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, and Berkeley Lights, Inc. (BLI), a leader in digital cell biology, today announced Catalent Biologics will adopt BLI’s Beacon®optofluidic platform to accelerate Catalent Biologics’ cell line development workflow. The Beacon platform is […]
Pairing epigenetic profiling with T cell receptor sequencing at single-cell resolution to advance cancer, immunology and stem cell research SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced a new bimodal single‑cell application available for use on the C1™ system. Offering a new assay to measure transposase-accessible chromatin […]
CARLSBAD, Calif. — International Stem Cell Corporation (OTCQB:ISCO) (“ISCO” or “the Company”), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that its wholly owned subsidiary, Lifeline Cell Technology (LCT), has expanded its business and manufacturing capabilities to fulfill current and forecasted demand. LCT has demonstrated stable manufacturing and […]
Entopsis has licensed cutting-edge research tools from its new PCRopsis™ product line for the Chinese market to Beijing Wan Bridge Intelligent Technology. Backed by patent pending technologies, PCRopsis™’s three cost- and time-saving solutions forsample processing are expected to usher in a new direction for laboratory R&D. Miami, Florida: Leading biotech R&D company Entopsis has recently licensed three state-of-the-art […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
